• 1
    Paulose-Ram R, Hirsch R, Dillon C, Losonczy K, Cooper M, Ostchega Y. Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III). Pharmacoepidemiol Drug Saf 2003; 12: 31526.
  • 2
    Wilcox CM, Cryer B, Triadafilopoulos G. Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs. J Rheumatol 2005; 32: 221824.
  • 3
    The American Association for Public Opinion Research standard definitions: final dispositions of case codes and outcome rates for surveys. 4th ed. Lenexa (KS): AAPOR; 2006.
  • 4
    Chan AT, Manson JE, Albert CM, Chae CU, Rexrode KM, Curhan GC, et al. Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation 2006; 113: 157887.
  • 5
    Singh G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med 1998; 105: S318.
  • 6
    Epstein M. Non-steroidal anti-inflammatory drugs and the continuum of renal dysfunction. J Hypertens 2002; 20 Suppl 6: S1723.
  • 7
    Gaziano JM. Nonnarcotic analgesics and hypertension. Am J Cardiol 2006; 97: 106.
  • 8
    Hermann M, Ruschitzka F. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk [published erratum appears in Intern J Med 2006;36:799]. Intern Med J 2006; 36: 30819.
  • 9
    Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: a meta-analysis. Ann Intern Med 1991; 115: 78796.
  • 10
    Naesdal J, Brown K. NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options. Drug Saf 2006; 29: 11932.
  • 11
    Katz JN, Daltroy LH, Brennan TA, Liang MH. Informed consent and the prescription of nonsteroidal antiinflammatory drugs. Arthritis Rheum 1992; 35: 125763.
  • 12
    McComas KA. Defining moments in risk communication research: 1996–2005. J Health Commun 2006; 11: 7591.
  • 13
    Groman R, Ginsburg J, and the American College of Physicians. Racial and ethnic disparities in health care: a position paper of the American College of Physicians. Ann Intern Med 2004; 141: 22632.
  • 14
    Belsley DA, Kuh E, Welsch RE. Regression diagnostics: identifying influential data and sources of collinearity. New York: John Wiley & Sons; 1980.
  • 15
    Rabe-Hesketh S, Skrondal A. Multilevel and longitudinal modeling using Stata. College Station (TX): Stata; 2005.
  • 16
    Rabe-Hesketh S, Skrondal A, Pickles A. Reliable estimation of generalized linear mixed models using adaptive quadrature. Stata J 2002; 2: 121.
  • 17
    Snijders TA, Bosker RJ. Multilevel analysis: an introduction to basic and advanced multilevel modeling. Thousand Oaks (CA): Sage; 1999.
  • 18
    Davison AC, Hinkley DV. Bootstrap methods and their application. Cambridge: Cambridge University; 1997.
  • 19
    Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman & Hall; 1993.
  • 20
    Agency for Healthcare Research and Quality. 2005 National Healthcare Disparities Report. Rockville (MD): AHQR; 2005
  • 21
    National Consumers League Survey: over-the-counter pain medications. URL: 2003.
  • 22
    Edwards A, Elwyn G, Wood F, Atwell C, Prior L, Houston H. Shared decision making and risk communication in practice: a qualitative study of GPs' experiences. Br J Gen Pract 2005; 55: 613.
  • 23
    Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294: 71624.
  • 24
    Boulware LE, Cooper LA, Ratner LE, LaVeist TA, Powe NR. Race and trust in the health care system. Public Health Rep 2003; 118: 35865.
  • 25
    Ashton CM, Haidet P, Paterniti DA, Collins TC, Gordon HS, O'Malley K, et al. Racial and ethnic disparities in the use of health services: bias, preferences, or poor communication? J Gen Intern Med 2003; 18: 14652.
  • 26
    Pincus T, Swearingen C, Cummins P, Callahan LF. Preference for nonsteroidal antiinflammatory drugs versus acetaminophen and concomitant use of both types of drugs in patients with osteoarthritis. J Rheumatol 2000; 27: 10207.
  • 27
    Sleath B, Rubin RH, Campbell W, Gwyther L, Clark T. Physician-patient communication about over-the-counter medications. Soc Sci Med 2001; 53: 35769.
  • 28
    De Young M. Research on the effects of pharmacist-patient communication in institutions and ambulatory care sites, 1969–1994. Am J Health Sys Pharm 1996; 53: 127791.
  • 29
    Schommer JC, Wiederholt JB. A field investigation of participant and environment effects on pharmacist-patient communication in community pharmacies. Med Care 1995; 33: 56784.
  • 30
    Allison JJ, Saag KG. Unbalanced regulation of over-the-counter analgesics: the lesser of two evils? Pharmacoepidemiol Drug Saf 2006; 15: 4101.
  • 31
    Spence MM, Teleki SS, Cheetham TC, Schweitzer SO, Millares M. Direct-to-consumer advertising of COX-2 inhibitors: effect on appropriateness of prescribing. Med Care Res Rev 2005; 62: 54459.
  • 32
    Hollon MF. Direct-to-consumer advertising: a haphazard approach to health promotion. JAMA 2005; 293: 20303.
  • 33
    Mebane FE. The importance of news media in pharmaceutical risk communication: proceedings of a workshop. Pharmacoepidemiol Drug Saf 2005; 14: 297306.
  • 34
    Singh G, Triadafilopoulos G. Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol 1999; 56: 1824.